Journals / Türk Nöroloji Dergisi / 2021 / Cilt: 27 - Sayı: 3

Relationship of Smoking with Fatigue and Depression in Patients with Multiple Sclerosis

Multipl Skleroz Hastalarında Sigaranın Yorgunluk ve Depresyon ile İlişkisi

Pages
289–294
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, smoking may be associated with the severity of patients’ depression.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The relationship between smoking and the risk and progression of multiple sclerosis (MS) is known.
📊
Key Findings & Data:These were smokers with MS (n=40), non-smokers with MS (n=40), and healthy smokers (n=50) groups.
💡
Conclusion & Impact:However, smoking may be associated with the severity of patients’ depression.
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The relationship between smoking and the risk and progression of multiple sclerosis (MS) is known. We investigated the role of smoking on fatigue, depression, and disability in patients with MS. Materials and Methods: Three groups were included in our study. These were smokers with MS (n=40), non-smokers with MS (n=40), and healthy smokers (n=50) groups. Patients were diagnosed as having MS according to the 2010 revised McDonald diagnostic criteria. This study used a sociodemographic follow-up form, the neurological fatigue index, Fagerstrom test for nicotine dependence, and Beck depression inventory. Results: We showed that MS patients felt more fatigue than healthy individuals, but there was no difference regarding fatigue levels between smokers with MS and non-smokers with MS. In addition, we determined that smoking increased the level of depression, or those with depression might be smoking more. Conclusion: We believe that smoking is not associated with MS fatigue. However, smoking may be associated with the severity of patients’ depression.

Özet

Amaç: Sigara içmekle, multipl skleroz (MS) riski ve hastalığın progresyonu arasında varolan ilişki bilinmektedir. Bu araştırmada, sigara içiminin MS hastalarında yorgunluk, depresyon ve özürlülük üzerine etkisinin araştırılması amaçlanmıştır. Gereç ve Yöntem: Çalışmamıza, 2010 revize McDonald tanı kriterlerine göre MS tanısı almış sigara içen ve içmeyen 40’ar hasta ve 50 sigara içen sağlıklı bireyden oluşan 3 grup dahil edildi. Bu çalışmada sosyodemografik takip formu, nörolojik yorgunluk indeksi, Fagerstrom nikotin bağımlılık testi ve Beck depresyon ölçeği kullanıldı. Bulgular: MS’li hastalarda yorgunluğun sağlıklı kişilere göre daha fazla olduğu, ancak sigara içen ve içmeyen MS hastalarının yorgunluk düzeyleri arasında anlamlı bir farklılık olmadığı saptandı. Bunun yanı sıra sigara içiminin depresyonun düzeyini artırdığı ya da depresyonu olanların daha fazla sigara kullanıyor olabileceği belirlendi. Sonuç: Sigara ile MS yorgunluğunun ilişkili olmadığını ancak sigara kullanımının hastaların depresyon düzeyi ile ilişkili olabileceğini düşünmekteyiz.

🔖

Cite This Article

ERTEN, M., FIRAT, Y. E., AKÇALI, A., GEYİK, S., ÇOMRUK, G., CENGİZ, E. K. (2022). Relationship of Smoking with Fatigue and Depression in Patients with Multiple Sclerosis. Türk Nöroloji Dergisi, Cilt: 27 - Sayı: 3, 289–294. https://ajindex.com/articles/636564

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Vandebergh M, Goris A. Smoking and multiple sclerosis risk: a Mendelian randomization study. J Neurol 2020;267:3083-3091
  2. Durazzo TC, Meyerhoff DJ, Nixon SJ. Chronic cigarette smoking: ımplications for neurocognition and brain neurobiology. Int J Environ Res Public Heal 2010;7:3760-3791
  3. Degens H, Gayan-Ramirez G, Van Hees HWH. Smoking-induced skeletal muscle dysfunction: from evidence to mechanisms. Am J Respir Crit Care Med 2015;191:620-625
  4. Wüst RCI, Christopher IM, De Haan A, et al. Skeletal muscle properties and fatigue resistance in relation to smoking history. Eur J Appl Physiol 2008;104:103-110
  5. Devasahayam AJ, Kelly LP, Wallack EM, Ploughman M. Oxygen cost during mobility tasks and ıts relationship to fatigue in progressive multiple sclerosis. Arch Phys Med Rehabil 2019;100:2079-2088
  6. Lee CL, Chang WD. The effects of cigarette smoking on aerobic and anaerobic capacity and heart rate variability among female university students. Int J Womens Health 2013;5:667-679
  7. Di Pauli F, Reindl M, Ehling R, et al. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult Scler 2008;14:1026- 1030
  8. Hedström AK, Hillert J, Olsson T, Alfredsson L. Smoking and multiple sclerosis susceptibility. Eur J Epidemiol 2013;28:867-874
  9. Riise T, Nortvedt MW, Ascherio A. Smoking is a risk factor for multiple sclerosis. Neurology 2003;61:1122-1124
  10. Zhang P, Wang R, Li Z, et al. The risk of smoking on multiple sclerosis: a meta-analysis based on 20,626 cases from case-control and cohort studies. PeerJ 2016;4:1-19
  11. Ciccolo JT, Lo AC, Jennings EG, Motl RW. Rationale and design of a clinical trial investigating resistance training as an aid to smoking cessation in persons with multiple sclerosis. Contemp Clin Trials 2012;33:848-852
  12. Dobson R, Giovannoni G. Multiple sclerosis-a review. Eur J Neurol 2019;26:27-40
  13. Weiland TJ, Jelinek GA, Marck CH, et al. Clinically significant fatigue: prevalence and associated factors in an international sample of adults with multiple sclerosis recruited via the internet. PLoS One 2015;10:e0115541
  14. Derksen A, Mokkink LB, Rietberg MB, et al. Validation of a Dutch version of the Neurological Fatigue Index (NFI-MS) for patients with multiple sclerosis in the Netherlands. Qual Life Res 2013;22:2435-2441
  15. Mills RJ, Young CA, Pallant JF, Tennant A. Development of a patient reported outcome scale for fatigue in multiple sclerosis: the Neurological Fatigue Index (NFI-MS)